4 MedTech Stocks Momentum Investors Will Love

Amid the present volatility across the global economy, we have found a handful of top Zacks Rank momentum stocks for you from the Medical Instrument industry (one of the 4 industries of the MedTech sector) that are going to gain from this share market turbulence. With a Style Score of “B” or better combined with favorable Zacks Rank #1 or #2 and a market cap of more than $100 million, these stocks are looking especially impressive right now.

Impressively, the medical instruments industry currently holds an impressive Zacks Industry Rank #73 (As a guideline, the outlook for industries with Zacks Industry Rank of #88 and lower is 'Positive.’ To learn more, visit: About Zacks Industry Rank.)

Below we have cited 4 stocks that are worth a look before you invest:

Thermo Fisher Scientific TMO: Expansion through M&A is one of the primary strategies played by this Massachusetts-based scientific instrument manufacturer. Apart from the $13.6 billion Life Technologies acquisition (Feb 2014), the company’s most recent buyouts include the impending purchase of U.K.-based research chemical manufacturer, Alfa Aesar and Advanced Scientifics. The metrics that make this leading scientific instrument provider all the more desirable are:

• Momentum Score of “A”
• Zacks Rank #2 (Buy)
• Market Cap: $49.85 billion.

Cyberonics CYBX: Cyberonics is a medical technology company with core expertise in neuromodulation. The $2.7 billion Sorin merger — expected to be over by Sep 22, 2015 — is likely to expand Cyberonics’ epilepsy business outside the U.S. The metrics that make the company more attractive are:

• Momentum Score of “A”
• Zacks Rank #1 (Strong Buy)
• Market Cap: $1.76 billion

Intuitive Surgical ISRG: This California-based medical device developer manufactures the da Vinci surgical system – an advanced robot-assisted surgical system. The latest version of the company’s da Vinci Xi robotic surgical system has longer instrument shafts enabling greater reach for surgery. The metrics that make this company all the more desirable are:

• Momentum Score of “B”
• Zacks Rank #2
• Market Cap: $19.02 billion

Natus Medical BABY: Natus is a leading provider of newborn care and neurology healthcare products and services. The company’s five-year Hearing Screening Coordination contract worth $32.5 million with the State of California is expected to position the company for accelerated revenue growth and record earnings in 2015. The metrics that make Natus an attractive choice are:

• Momentum Score of “B”
• Zacks Rank #2
• Market Cap: $1.36 billion

Bottom Line

You can find stocks with good momentum scores any time of the year, but the present market scenario makes the task a little difficult. All of the aforementioned stocks may not be big, but they certainly make a bang in the MedTech sector. If the worldwide bullish market continues for a few more days, these stocks have a high chance of performing well in the near future.  

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>